A newly identified cancer pathway may finally reveal how to stop pancreatic tumors before they spread. A Cornell-led research effort has uncovered how a highly aggressive type of pancreatic cancer is ...

CorriXR Therapeutics, an oncology-focused biotherapeutics company pioneering a ground-breaking gene editing platform technology, InhaTarget Therapeutics, a company dedicated to the early development ...

Investigator-Initiated Preclinical studies at CIC biomaGUNE aimed at combatting Glioblastoma Multiforme Research will evaluate effects of intra-arterial delivery of Annamycin HOUSTON, Dec. 08, 2025 ...

This article explores how single-cell multiomics and spatial transcriptomics are illuminating early pregnancy, uncovering ...

Research presented by Professor Cecilia Johansson of Imperial College London has linked early type I interferon signalling in ...

Glioblastoma is one of the most lethal brain cancers known, and for decades treatment has barely budged survival curves despite surgery, radiation, and chemotherapy. Now researchers are testing a ...

Scientists are closing in on a deceptively simple idea with radical implications: that a single protein signal in the blood ...

A multidisciplinary team integrated clinical need, cancer biology, and microfluidic bioengineering to advance ...

The U.S. Food and Drug Administration has approved Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the first and ...

Overcoming acquired treatment resistance is one of the major challenges in the fight against cancer. While combination ...

Data from a new mouse model may help advance therapeutic development in celiac disease, including improved TG2 inhibitors and ...

For over a century, Alzheimer's disease (AD) has been considered irreversible. Consequently, research has focused on disease prevention or slowing, rather than recovery.